Last 47 quarters of trend data · Healthcare · Medical - Diagnostics & Research
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 21.94 | 19.55 | 30.33 | 22.76 | 18.62 | 27.31 | 24.48 | 27.93 | 26.63 | — | 30.71 | 26.16 | 30.68 | 33.16 | 32.04 | 33.05 | 30.40 | 29.79 | 19.39 | 26.31 | 24.04 |
| — | -28.4% | +23.9% | -18.5% | -30.1% | — | -20.3% | +6.7% | -13.2% | — | -4.2% | -20.8% | +0.9% | +11.3% | +65.3% | +25.6% | +26.5% | +20.8% | -15.9% | +70.9% | -87.9% | |
| P/S Ratio | 4.42 | 3.80 | 4.25 | 4.55 | 4.58 | 4.91 | 4.57 | 4.79 | 5.23 | 4.73 | 5.46 | 5.06 | 5.05 | 5.39 | 5.61 | 5.93 | 5.04 | 5.58 | 4.76 | 5.86 | 5.95 |
| — | -22.7% | -7.1% | -5.0% | -12.4% | +4.0% | -16.3% | -5.4% | +3.6% | -12.4% | -2.7% | -14.7% | +0.2% | -3.4% | +17.9% | +1.2% | -15.3% | +6.4% | -10.0% | +1.8% | -11.9% | |
| P/B Ratio | 2.46 | 2.42 | 2.51 | 2.60 | 2.67 | 2.99 | 2.59 | 2.80 | 2.97 | 2.75 | 2.78 | 2.71 | 2.60 | 2.95 | 3.06 | 3.41 | 3.03 | 3.51 | 3.69 | 4.41 | 4.22 |
| — | -19.1% | -3.2% | -7.0% | -10.1% | +8.6% | -6.8% | +3.4% | +14.4% | -6.5% | -9.0% | -20.6% | -14.0% | -16.0% | -17.1% | -22.7% | -28.3% | -12.3% | -12.3% | -6.2% | -12.4% | |
| P/FCF | 20.36 | 12.88 | 38.91 | 20.98 | 20.51 | 21.74 | 23.06 | 17.60 | 19.02 | 18.36 | 26.44 | 25.99 | 28.72 | 33.22 | 81.25 | 38.00 | 13.62 | 21.42 | 17.69 | 23.64 | 30.51 |
| — | -40.8% | +68.7% | +19.2% | +7.8% | +18.4% | -12.8% | -32.3% | -33.8% | -44.7% | -67.5% | -31.6% | +110.9% | +55.1% | +359.3% | +60.7% | -55.4% | -20.7% | -56.5% | +45.9% | — | |
| EV / EBITDA | 14.07 | 15.83 | 13.95 | 13.10 | 9.99 | 16.33 | 15.09 | 16.60 | 17.66 | — | 18.44 | 17.46 | 17.78 | 19.09 | 20.86 | 20.36 | 18.73 | 18.45 | 12.62 | 16.44 | 18.97 |
| — | -3.1% | -7.5% | -21.1% | -43.4% | — | -18.2% | -5.0% | -0.7% | — | -11.6% | -14.2% | -5.1% | +3.5% | +65.2% | +23.9% | -1.3% | +22.1% | -15.7% | -3.4% | -49.7% | |
| EV / EBIT | 19.31 | 15.83 | 24.17 | 22.32 | 18.42 | 20.82 | 18.94 | 19.95 | 22.37 | — | 24.45 | 21.57 | 23.29 | 25.81 | 25.18 | 26.86 | 24.75 | 24.65 | 15.70 | 20.73 | 21.15 |
| — | -24.0% | +27.6% | +11.9% | -17.7% | — | -22.5% | -7.5% | -3.9% | — | -2.9% | -19.7% | -5.9% | +4.7% | +60.4% | +29.6% | +17.0% | +23.5% | -17.4% | +56.2% | -73.0% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 61.8% | 63.6% | 62.9% | 58.7% | 62.2% | 62.7% | 63.8% | 63.9% | 61.4% | 7.0% | 63.4% | 62.1% | 62.6% | 63.1% | 63.3% | 63.8% | 64.3% | 64.2% | 66.0% | 64.2% | 63.1% |
| — | +1.5% | -1.5% | -8.2% | +1.2% | +794.6% | +0.7% | +3.0% | -1.9% | -88.9% | +0.1% | -2.6% | -2.6% | -1.8% | -4.1% | -0.7% | +1.9% | -1.3% | +1.1% | -1.8% | -4.9% | |
| Operating Margin | 24.9% | 24.7% | 23.7% | 28.5% | 24.3% | 22.8% | 23.9% | 22.9% | 22.3% | -46.0% | 20.7% | 21.7% | 20.4% | 21.3% | 19.9% | 21.0% | 19.5% | 23.7% | 33.0% | 29.7% | 24.7% |
| — | +8.3% | -0.7% | +24.6% | +8.6% | +149.6% | +15.3% | +5.2% | +9.4% | -316.0% | +3.9% | +3.5% | +4.5% | -10.1% | -39.5% | -29.4% | -20.7% | -16.6% | +14.1% | +8.9% | +168.0% | |
| Net Margin | 20.3% | 19.3% | 13.8% | 20.0% | 24.4% | 18.0% | 18.8% | 16.9% | 19.5% | -37.0% | 17.6% | 19.2% | 16.4% | 16.3% | 17.5% | 17.8% | 16.5% | 18.8% | 24.7% | 22.2% | 24.9% |
| — | +7.1% | -26.4% | +17.7% | +25.0% | +148.8% | +6.8% | -11.7% | +19.5% | -326.4% | +0.4% | +7.5% | -0.8% | -12.9% | -29.1% | -19.6% | -33.8% | -12.1% | +8.5% | -40.4% | +612.3% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 11.6% | 3.1% | 1.9% | 2.9% | 3.6% | 2.8% | 2.6% | 2.5% | 2.8% | -5.2% | 2.2% | 2.6% | 2.1% | 2.2% | 2.4% | 2.6% | 2.5% | 3.0% | 4.9% | 4.2% | 4.4% |
| — | +11.0% | -26.4% | +16.7% | +28.5% | +153.2% | +19.5% | -4.4% | +32.9% | -332.9% | -10.0% | -0.4% | -14.7% | -24.1% | -50.6% | -38.2% | -43.9% | -28.7% | +7.1% | -45.2% | +600.6% | |
| ROA | 7.1% | 1.8% | 1.1% | 1.7% | 2.1% | 1.7% | 1.6% | 1.5% | 1.7% | -3.2% | 1.4% | 1.6% | 1.3% | 1.3% | 1.4% | 1.4% | 1.3% | 1.6% | 2.5% | 2.1% | 2.2% |
| — | +4.6% | -30.3% | +13.6% | +27.0% | +152.6% | +19.4% | -9.1% | +30.2% | -351.7% | +0.0% | +17.1% | -2.3% | -18.3% | -46.3% | -34.5% | -41.6% | -24.5% | +13.4% | -42.0% | +629.1% | |
| ROIC | 8.6% | 2.3% | 2.0% | 2.6% | 2.2% | 2.2% | 2.0% | 2.0% | 1.9% | -3.9% | 1.5% | 1.8% | 1.5% | 1.6% | 1.5% | 1.7% | 1.7% | 2.1% | 3.6% | 3.0% | 2.3% |
| — | +6.4% | -1.6% | +28.9% | +16.7% | +156.3% | +31.7% | +12.9% | +25.2% | -344.1% | +1.1% | +0.6% | -7.2% | -22.8% | -58.6% | -42.6% | -29.0% | -30.8% | +19.7% | +6.7% | +167.6% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.44 | 0.49 | 0.49 | 0.44 | 0.58 | 0.41 | 0.41 | 0.45 | 0.54 | 0.41 | 0.42 | 0.44 | 0.40 | 0.52 | 0.53 | 0.54 | 0.69 | 0.59 | 0.60 | 0.63 | 0.64 |
| — | +18.8% | +19.6% | -2.9% | +7.2% | +0.1% | -1.0% | +1.6% | +35.5% | -21.0% | -20.9% | -18.3% | -41.6% | -11.6% | -12.0% | -14.3% | +6.9% | -9.5% | -11.4% | -8.8% | -2.4% | |
| Debt / EBITDA | 2.32 | 11.56 | 9.81 | 8.14 | 8.07 | 8.43 | 8.84 | 9.77 | 11.84 | — | 10.07 | 10.42 | 10.04 | 12.06 | 12.64 | 11.83 | 15.47 | 11.22 | 7.47 | 8.76 | 10.49 |
| — | +37.2% | +10.9% | -16.7% | -31.8% | — | -12.2% | -6.2% | +18.0% | — | -20.3% | -11.9% | -35.1% | +7.5% | +69.1% | +35.1% | +47.5% | +25.1% | -15.0% | -4.1% | -44.1% | |
| Current Ratio | 3.90 | 2.85 | 3.21 | 3.90 | 2.60 | 1.61 | 3.37 | 3.61 | 2.17 | 1.77 | 1.84 | 1.99 | 3.74 | 2.36 | 2.53 | 2.46 | 1.84 | 2.23 | 2.19 | 1.39 | 1.90 |
| — | +76.7% | -4.6% | +8.1% | +19.6% | -8.8% | +82.8% | +81.2% | -41.9% | -25.2% | -27.1% | -19.0% | +103.4% | +6.0% | +15.4% | +76.7% | -2.9% | -37.8% | -34.3% | -51.0% | +30.2% | |
| Quick Ratio | 3.31 | 2.31 | 2.57 | 3.31 | 2.30 | 1.35 | 2.83 | 3.09 | 1.89 | 1.46 | 1.45 | 1.62 | 2.98 | 1.96 | 2.10 | 2.09 | 1.62 | 1.89 | 1.85 | 1.17 | 1.58 |
| — | +71.0% | -9.1% | +6.9% | +21.8% | -7.2% | +94.6% | +90.8% | -36.6% | -25.7% | -30.9% | -22.4% | +83.6% | +3.7% | +13.3% | +77.9% | +2.7% | -34.8% | -31.3% | -49.6% | +29.4% | |
| Interest Coverage | 15.74 | 14.18 | 8.77 | 11.77 | 17.39 | 17.68 | 17.39 | 12.29 | 11.14 | -19.46 | 10.94 | 10.56 | 8.67 | 8.58 | 8.53 | 8.12 | 6.88 | 9.46 | 15.44 | 14.28 | 11.39 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying QGEN stock.
Qiagen N.V.'s current P/E is 21.9x. The average P/E over the last 4 quarters is 22.8x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Qiagen N.V.'s current operating margin is 24.9%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Qiagen N.V.'s business trajectory between earnings reports.